Fatal Mucor pneumonia after treatment with 2-chlorodeoxyadenosine for non-Hodgkin's-lymphoma

Annals of Hematology

Volumn 73, Issue 3, 1996, Pages 145-147

  Szelenyi H ^a   Foss, H D ^a   Kreuser, E D ^a   Knauf, W ^a   Thiel, E ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

2 chlorodeoxyadenosine; Lymphoma; Mucor pneumonia

Indexed keywords

AMIKACIN; CHLORAMBUCIL; CLADRIBINE; COTRIMOXAZOLE; PIPERACILLIN; PREDNISONE;

AGED; ARTICLE; ASPERGILLUS; BRONCHOSCOPY; CANDIDA; CASE REPORT; HUMAN; HUMAN CELL; HUMAN TISSUE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOR; MYCOSIS; NECROSIS; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PNEUMONIA; PRIORITY JOURNAL; T LYMPHOCYTE;

AGED; CLADRIBINE; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, NON-HODGKIN; MALE; MUCORMYCOSIS; PNEUMONIA;

EID: 0029764013     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050217     Document Type: Article

References (14)

1. Betticher-DC, Fey-MF, von-Rohr-A, et al (1994) High incidence of infections after 2-chlorodeoxyadenosine (2-CDA) therapy in patients with malignant lymphomas and chronic and acute leukaemias. Ann Oncol 5:57-64
2. Beutler E, Piro LD, Saven A, et al (1991) 2′-Chlorodeoxyadenosine (2-CDA): a potent chemotherapeutic and immunosuppresive nucleoside. Leuk Lymphoma 5:1-8
3. Carrera CJ, Piro LD, Saven A, et al (1990) Restoration of lymphocyte subsets following 2′-chlorodeoxyadenosine remission induction in hairy cell leukemia. Blood 76 [Suppl 1]:260a
4. Donhuijsen K, Grothey A, Völker B, Dermoumi H (1991) Zykomkosen: Klinik und Pathologie bei 10 Patienten. Schweiz Med Wochenschr 121:1493-1498
5. Gaziev BD, Baronciani D, Galimbeti M et al. (1996) Mucormycosis after bone marrow transplantation: report of four cases in thalassemia and review of the literature. Bone Marrow Transplant 17:409-414
6. Juliosson G, Liliemark J (1992) Rapid recovery from cytopenia in hairy cell leukemia after treatment with 2′-chlorodeoxyadenosine (2 CDA): relation to opportunistic infections. Blood 79:888-892
7. Kay AC, Saven A, Carrera CJ et al. (1992) 2′-chlorodeoxyadenosine treatment of low-grade lymphoma. J Clin Oncol 10:371-377
8. O'Dwyer PJ, Wagner B, Leyland -Jones B, Wittes RE, Cheson BD, Hoth DF (1988) 2′-Deoxycycoformycin (pentostatin) for lymphoid malignancies: rational development of an active new drug. Ann Intern Med 108:733-743
9. Richardson MR, Warnock DW (1993) Mucormycosis. In: Richardson MD, Warnock DW (eds) Fungal infection. Blackwell Scientific Publications, Oxford, pp 123-128
10. Saven A, Piro LD (1994) Newer purine analogues for the treatment of hairy cell leukemia. N Engl J Med 330:691-697
11. Seymour JF, Kurzrock R, Freireich EJ, Estey EH (1992) Prolonged CD 4+ lymphocytopenia is the cost of durable responses to 2′-chlorodeoxyadenosine (2-CDA) in patient with hairy cell leukemia. Blood 82 [Suppl] :42a
12. Saven A, Piro LD (1994) 2′-chlorodeoxyadenosine: a newer purine analog active in the treatment of indolent lymphoid malignancy. Ann Intern Med 120:784-791
13. Seymour-JF, Kurzrock-R, Freireich-EJ, Estey-EH (1994) 2-Chlorodeoxyadenosine induces durable remissions and prolonged suppression of CD4+ lymphocyte counts in patients with hairy cell leukemia. Blood 83:2906-2911
14. Walsh TJ, Rinalde MR, Pizzo PA (1993) Zygomyces of the respiratory tract. In: Sarosi GA, Davies SF (eds) Fungal diseases of the lung, Raven, New York, pp 149-170